Search

everythinglearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Testosterone boosts fluid and electrolyte secretion in seminal vesicles, aiding sperm function.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Testosterone increases certain kidney protein levels, potentially raising blood pressure.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Tamsulosin increases the risk of floppy iris syndrome during cataract surgery.

A 3D model of Dupuytren’s disease was developed for better drug testing.

Low-dose finasteride may increase erectile dysfunction risk over time.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Early onset baldness may be linked to thicker artery walls.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

Tissue stiffness is influenced by contractility, which suppresses collagen breakdown.